Single Use Support in the midst of change in the healthcare industry

micheal-eder

Michael Eder

September 21, 2023

Table of contents

Show

In the wake of the pandemic, the biotech industry is in a state of upheaval: more and more new drugs are being developed and produced. The Tyrolean company Single Use Support is actively involved in this process and continues to grow.

KUFSTEIN, September 21, 2023 - Chemotherapies are being replaced on a large scale by novel antibody therapies. Gene therapies are making it possible to cure diseases that are still considered incurable today. And novel vaccines are helping us manage viral and bacterial infections like RSV and Lyme disease. 
Single Use Support is at the heart of the development and production of these medicines. Thanks to innovative solutions for the safe handling of pharmaceuticals, more and more renowned companies around the world are relying on technologies from Kufstein.

Problem solver

In the development and production of novel drugs, biotechnology companies are increasingly facing challenges in the process chain and in the handling of liquid drugs. After all, great importance is attached to making the process as efficient as possible and with low product losses. To achieve this, more and more use is being made of single-use support. By automating the filling, freezing, storage and transport of liquids, complex process steps can be optimized and adapted to the respective customer requirements. For the benefit of the patient.

Global expansion

Single Use Support continuously receives new major orders from the USA, Europe and Asia. These come both from existing customers, in order to further expand the use of the technologies, and from new customers, who rely on the company from Tyrol for new active ingredients. With sites in Kufstein, Hall in Tyrol and, from the end of 2023, also in Boston in the USA, the company is already positioning itself for further growth in the coming years. At all locations, employees are sought who want to contribute to the development of new therapies to advance the healing of diseases.

Career opportunities: jobs.susupport.com

DSCF0046
micheal-eder

Michael Eder

Senior Marketing Manager

Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 8+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide. 

More from Michael Eder

Vaccines

The development process of biosimilars

The development process of biosimilars slightly differs from the one of their reference biologics. In this article, we will discuss each phase in detail.

micheal-eder

Michael Eder

May 13, 2024

Vaccines

Biomanufacturing: Process, steps and challenges in manufacturing biologics

As biologics have become a central pillar in today’s healthcare sector, their manufacturing process increasingly draws attention. In this article, we will discuss the process step by step, including challenges and possible ways to overcome them.

micheal-eder

Michael Eder

May 13, 2024

Read more about News

News

Sustainability Report: Commitment to Protecting Life and the Environment

Discover Single Use Supports sustainability goals, social impact, environmental impact, and industry impact in the fluid and cold chain management as part of the biopharmaceutical industry.

Armin Lassl - Single Use Support

Armin Lassl

April 29, 2024

News

Controlled Freezing to -170°C: Single Use Support & SCHOTT Pharma Join Forces

SCHOTT Pharma AG & Co. KGaA and Single Use Support GmbH are joining forces to extensively test SCHOTT Pharma’s innovative solutions for the safe and efficient handling of small volumes of pharmaceuticals at ultra-low temperatures.

micheal-eder

Michael Eder

May 24, 2023

News

Single Use Support launches IRIS single-use bag line

Austrian solution provider Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. 

micheal-eder

Michael Eder

October 17, 2022

Single-use Consumables

Case Study - Reducing Product Loss | Process-independence

Optimize process operations and save both, CAPEX and OPEX, when you plan to expand product capacities for biopharmaceutical manufacturing - especially for greenfield facilities. Read how you gain process-independence which in turn increases (cost-)efficiency in manufacturing processes.

Claus Exenberger - Single Use Support

Claus Exenberger

August 22, 2022